No evidence for relevant impact of renal replacement therapy on clinical effect of erythromycin in critically ill patients with sepsis
CC BY
Saved in:
Main Authors: | Tom D. Y., Reijnders, Hessel, Peters-Sengers, Tom van der, Poll |
---|---|
Format: | Book |
Language: | English |
Published: |
Springer
2023
|
Subjects: | |
Online Access: | https://link.springer.com/article/10.1186/s13054-023-04359-z https://dlib.phenikaa-uni.edu.vn/handle/PNK/7019 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How I prescribe prolonged intermittent renal replacement therapy
by: Edward G., Clark, et al.
Published: (2023) -
Changes of cardiac output and velocity time integral in blood return at the end of renal replacement therapy predict fluid responsiveness in critically Ill patients with acute circulatory failure
by: Daozheng, Huang, et al.
Published: (2023) -
Rationale for sequential extracorporeal therapy (SET) in sepsis
by: Claudio, Ronco, et al.
Published: (2023) -
The cytokine adsorber Cytosorb® does not reduce ammonia concentrations in critically ill patients with liver failure
by: Uwe, Liebchen, et al.
Published: (2023) -
Acute renal failure in practice /
by: Paul Glynne
Published: (2002)